Works matching IS 02780232 AND DT 2013 AND VI 31

Results: 75

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 179, doi. 10.1002/hon.2036

By:

Zinzani, Pier Luigi;
Pellegrini, Cinzia;
Merla, Emanuela;
Ballerini, Filippo;
Fabbri, Alberto;
Guarini, Attilio;
Pavone, Vincenzo;
Quintini, Gerlando;
Puccini, Benedetta;
Vigliotti, Maria Luigia;
Stefoni, Vittorio;
Derenzini, Enrico;
Broccoli, Alessandro;
Gandolfi, Letizia;
Quirini, Federica;
Casadei, Beatrice;
Argnani, Lisa;
Baccarani, Michele

Publication type:

Article

Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.

Published in:

Hematological Oncology, 2013, v. 31, n. 3, p. 136, doi. 10.1002/hon.2032

By:

Orlandi, Ester M.;
Bernasconi, Paolo;
Pascutto, Cristiana;
Giardini, Ilaria;
Cavigliano, Paola M.;
Boni, Marina;
Zibellini, Silvia;
Cazzola, Mario

Publication type:

Article

Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 218, doi. 10.1002/hon.2048

By:

Berrang, Tanya;
Holloway, Caroline;
Hart, Jason;
Yee, Adrian;
Berry, Brian;
Kotb, Rami

Publication type:

Article

Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 201, doi. 10.1002/hon.2044

By:

Pappa, CA;
Alexandrakis, MG;
Boula, A;
Psarakis, FE;
Kolovou, A;
Bantouna, V;
Stavroulaki, E;
Tsirakis, G

Publication type:

Article

Erratum: Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. 168, doi. 10.1002/hon.2112
Publication type:: Article

Timing of antibiotic administration and outcomes in patients with chemotherapy-induced febrile neutropenia.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 221, doi. 10.1002/hon.2045

By:

Ahn, Shin;
Lee, Yoon‐Seon;
Lim, Kyung Soo;
Lee, Jae‐Lyun

Publication type:

Article

Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 213, doi. 10.1002/hon.2038

By:

Fabbri, Alberto;
Cencini, Emanuele;
Pietrini, Alice;
Gozzetti, Alessandro;
Defina, Marzia;
Fontanelli, Giulia;
Mazzei, Maria Antonietta;
Volterrani, Luca;
Bocchia, Monica

Publication type:

Article

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 223, doi. 10.1002/hon.2049

By:

Zinzani, Pier Luigi;
Pellegrini, Cinzia;
Derenzini, Enrico;
Argnani, Lisa;
Pileri, Stefano

Publication type:

Article

Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 189, doi. 10.1002/hon.2040

By:

Lynn, Jiun‐Jen;
Chen, Kuan‐Fu;
Weng, Yi‐Ming;
Chiu, Te‐Fa

Publication type:

Article

Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 206, doi. 10.1002/hon.2051

By:

Xue, Sheng‐Li;
Cui, Hong‐Xia;
Zou, Jing‐Ying;
Xue, Meng‐Xing;
Tang, Xiao‐Wen;
Zhang, Yan‐Ming;
Wu, De‐Pei

Publication type:

Article

Rituximab maintenance versus retreatment in follicular lymphoma.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 171, doi. 10.1002/hon.2033

By:

Palla, Amruth R.;
Hamadani, Mehdi

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. i, doi. 10.1002/hon.2104
Publication type:: Article

Sorafenib in patients with refractory or recurrent multiple myeloma.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 197, doi. 10.1002/hon.2043

By:

Yordanova, Anna;
Hose, Dirk;
Neben, Kai;
Witzens‐Harig, Mathias;
Gütgemann, Ines;
Raab, Marc‐Steffen;
Moehler, Thomas;
Goldschmidt, Hartmut;
Schmidt‐Wolf, Ingo GH

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2013, v. 31, n. 4, p. i, doi. 10.1002/hon.2128
Publication type:: Article

Erratum: Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. 167, doi. 10.1002/hon.2108
Publication type:: Article

Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 183, doi. 10.1002/hon.2039

By:

Zinzani, Pier Luigi;
Pellegrini, Cinzia;
Gandolfi, Letizia;
Casadei, Beatrice;
Derenzini, Enrico;
Broccoli, Alessandro;
Quirini, Federica;
Argnani, Lisa;
Pileri, Stefano;
Celli, Monica;
Fanti, Stefano;
Poletti, Venerino;
Stefoni, Vittorio;
Baccarani, Michele

Publication type:

Article

A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients.

Published in:

Hematological Oncology, 2013, v. 31, n. 3, p. 117, doi. 10.1002/hon.2031

By:

Girmenia, Corrado;
Aversa, Franco;
Busca, Alessandro;
Candoni, Anna;
Cesaro, Simone;
Luppi, Mario;
Pagano, Livio;
Rossi, Giuseppe;
Venditti, Adriano;
Nosari, Anna Maria

Publication type:

Article

Erratum: Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. 169, doi. 10.1002/hon.2113
Publication type:: Article

Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy.

Published in:

Hematological Oncology, 2013, v. 31, n. 3, p. 151, doi. 10.1002/hon.2035

By:

Gobbi, Paolo G.;
Bergonzi, Manuela;
Bassi, Emilio;
Merli, Francesco;
Coriani, Chiara;
Federico, Massimo

Publication type:

Article

Erratum: Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. 168, doi. 10.1002/hon.2111
Publication type:: Article

Chromosome abnormalities in diffuse large B-cell lymphomas: analysis of 231 Chinese patients.

Published in:

Hematological Oncology, 2013, v. 31, n. 3, p. 127, doi. 10.1002/hon.2030

By:

Zhao, Xiaoli;
Fan, Rong;
Lin, Guowei;
Wang, Xiaoqin

Publication type:

Article

Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib.

Published in:

Hematological Oncology, 2013, v. 31, n. 3, p. 164, doi. 10.1002/hon.2024

By:

Dasanu, Constantin A.;
Bauer, Frank;
Codreanu, Ion;
Padmanabhan, Premkumar;
Rampurwala, Murtuza

Publication type:

Article

Erratum: Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. 167, doi. 10.1002/hon.2109
Publication type:: Article

Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study.

Published in:

Hematological Oncology, 2013, v. 31, n. 3, p. 156, doi. 10.1002/hon.2034

By:

Uchiyama, Takayoshi;
Sato, Naoya;
Narita, Miwako;
Yamahira, Akie;
Iwabuchi, Minami;
Furukawa, Tatsuo;
Sone, Hirohito;
Takahashi, Masuhiro

Publication type:

Article

Erratum: Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. 168, doi. 10.1002/hon.2110
Publication type:: Article

Erratum: The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblasts.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. 169, doi. 10.1002/hon.2114
Publication type:: Article

Erratum: Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patients.

Published in:: Hematological Oncology, 2013, v. 31, n. 3, p. 167, doi. 10.1002/hon.2107
Publication type:: Article

Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.

Published in:

Hematological Oncology, 2013, v. 31, n. 3, p. 143, doi. 10.1002/hon.2037

By:

Mappa, Silvia;
Marturano, Emerenziana;
Licata, Giada;
Frezzato, Maurizio;
Frungillo, Niccolò;
Ilariucci, Fiorella;
Stelitano, Caterina;
Ferrari, Antonella;
Sorarù, Mariella;
Vianello, Fabrizio;
Baldini, Luca;
Proserpio, Ilaria;
Foppoli, Marco;
Assanelli, Andrea;
Reni, Michele;
Caligaris‐Cappio, Federico;
Ferreri, Andrés J. M.

Publication type:

Article

V. Molecular classification and risk stratification of myeloma.

Published in:

Hematological Oncology, 2013, v. 31, p. 38, doi. 10.1002/hon.2065

By:

Bergsagel, P. Leif;
Chesi, Marta

Publication type:

Article

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

Published in:

Hematological Oncology, 2013, v. 31, p. 64, doi. 10.1002/hon.2069

By:

Woessmann, Wilhelm

Publication type:

Article

POSTER PRESENTATIONS.

Published in:: Hematological Oncology, 2013, v. 31, p. 151, doi. 10.1002/hon.2058
Publication type:: Article

AGENDA AND ABSTRACTS OF SATELLITE SYMPOSIA.

Published in:: Hematological Oncology, 2013, v. 31, p. 279, doi. 10.1002/hon.2060
Publication type:: Article

XIII. Waldenström's macroglobulinaemia: an indolent B-cell lymphoma with distinct molecular and clinical features.

Published in:

Hematological Oncology, 2013, v. 31, p. 76, doi. 10.1002/hon.2071

By:

Treon, Steven P.

Publication type:

Article

VIII. New markers in peripheral T-cell lymphomas: more entities or more confusion?

Published in:

Hematological Oncology, 2013, v. 31, p. 51, doi. 10.1002/hon.2082

By:

Gaulard, Philippe;
Leval, Laurence

Publication type:

Article

IV. Initial treatment of multiple myeloma.

Published in:

Hematological Oncology, 2013, v. 31, p. 33, doi. 10.1002/hon.2064

By:

Rajkumar, S. Vincent

Publication type:

Article

XVII. Radiotherapy in early stage Hodgkin lymphoma.

Published in:

Hematological Oncology, 2013, v. 31, p. 92, doi. 10.1002/hon.2075

By:

Illidge, Tim

Publication type:

Article

ORAL PRESENTATIONS.

Published in:: Hematological Oncology, 2013, v. 31, p. 96, doi. 10.1002/hon.2057
Publication type:: Article

IX. Chronic lymphocytic leukaemia: New genetic markers as prognostic factors.

Published in:

Hematological Oncology, 2013, v. 31, p. 57, doi. 10.1002/hon.2068

By:

Rossi, Davide

Publication type:

Article

XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.

Published in:

Hematological Oncology, 2013, v. 31, p. 69, doi. 10.1002/hon.2070

By:

Jagadeesh, Deepa;
Diefenbach, Catherine;
Evens, Andrew M.

Publication type:

Article

X. Extra-nodal lymphoma in rare localisations: bone, breast and testes.

Published in:

Hematological Oncology, 2013, v. 31, p. 60, doi. 10.1002/hon.2081

By:

Seymour, John F.

Publication type:

Article

III. Applying molecular phenotyping in practice.

Published in:

Hematological Oncology, 2013, v. 31, p. 29, doi. 10.1002/hon.2063

By:

Johnson, Peter W. M.;
Davies, Andrew;
Jack, Andrew

Publication type:

Article

XVI. CNS prophylaxis in aggressive lymphomas: for whom and how.

Published in:

Hematological Oncology, 2013, v. 31, p. 89, doi. 10.1002/hon.2074

By:

Benevolo, Giulia;
Chiappella, Annalisa;
Vitolo, Umberto

Publication type:

Article

I. Pathological and clinical diversity in diffuse large B-cell lymphoma.

Published in:

Hematological Oncology, 2013, v. 31, p. 23, doi. 10.1002/hon.2056

By:

Piris, Miguel A.

Publication type:

Article

VII. Management of nodular lymphocyte-predominant Hodgkin lymphoma.

Published in:

Hematological Oncology, 2013, v. 31, p. 47, doi. 10.1002/hon.2067

By:

Eichenauer, Dennis A.;
Engert, Andreas

Publication type:

Article

II. Therapy of DLBCL based on genomics.

Published in:

Hematological Oncology, 2013, v. 31, p. 26, doi. 10.1002/hon.2062

By:

Staudt, Louis M.

Publication type:

Article

XV. Malignant lymphoma as a consequence of clonal evolution.

Published in:

Hematological Oncology, 2013, v. 31, p. 84, doi. 10.1002/hon.2073

By:

Seto, Masao

Publication type:

Article

ONGOING TRIALS.

Published in:: Hematological Oncology, 2013, v. 31, p. 271, doi. 10.1002/hon.2084
Publication type:: Article

ACKNOWLEDGEMENTS.

Published in:: Hematological Oncology, 2013, v. 31, p. 1, doi. 10.1002/hon.2055
Publication type:: Article

Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.

Published in:

2013

By:

Travella, Ana;
Ripollés, Lorena;
Aventin, Anna;
Rodríguez, Andrea;
Bezares, Raimundo F;
Caballín, María R;
Slavutsky, Irma

Publication type:

Journal Article

Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patients.

Published in:

2013

By:

Ghesquières, Hervé;
Drouet, Youenn;
Sunyach, Marie Pierre;
Sebban, Catherine;
Chassagne-Clement, Catherine;
Jouanneau, Emmanuel;
Honnorat, Jérome;
Biron, Pierre;
Blay, Jean Yves

Publication type:

Journal Article